Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_provenance.
- NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_assertion description "[We identified TET2 deletions in 50/893 patients (26 males, 24 females; 44-87 years) resulting in a 5.6% frequency [22/425 AML (5.2%), 15/217 chronic myelomonocytic leukaemia (CMML; 6.9%), 9/188 myelodysplastic syndromes (4.8%), 4/63 myeloproliferative neoplasms (6.3%)].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_provenance.
- NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_assertion evidence source_evidence_literature NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_provenance.
- NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_assertion SIO_000772 22017486 NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_provenance.
- NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_assertion wasDerivedFrom befree-20140225 NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_provenance.
- NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_assertion wasGeneratedBy ECO_0000203 NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP203797.RA9oaz6-FbAAqzJyK7MFCwfawAi04J1i7swLdp4BKA-rE130_provenance.